CDK14 and ovarian carcinoma: However, according to the reported studies [18], CDK14 is a target of miR-128-3p and miR-128-3p downregulation increases CDK14 expression and thus promotes cell proliferation, migration, invasion and inhibits apoptosis in ovarian cancer.